Happy Holidays from Clinakos
Warm holiday greetings and a Happy New Year 2024 to everyone! As we bid farewell to an outstanding 2023, Clinakos Inc. celebrates our remarkable growth and continued recognition from clients, partners, and patients. Your unwavering support is deeply appreciated, and we eagerly look forward to expanding our partnership in the upcoming year. Here’s to a prosperous […]
Join us at Piper Sandler’s 35th Annual Healthcare Conference
Join Clinakos Inc. at Piper Sandler ‘s 35th Annual Healthcare Conference in New York. Our team will be on-site from Tuesday, November 28th to Thursday, November 30th, engaging with clients and forging new partnerships.
Happy Thanksgiving from Clinakos
As we usher into the holiday season, Clinakos thanks and salutes our customers, partners, employees and patients for a yet another phenomenal year of growth. We remain committed to our mission of bettering human health through solutions built on the top of Integrated Patient Data and Medically Smart AI. Wishing you all a Thanksgiving filled […]
Over 375 industry leaders from 55+ Pharma & Biotech companies registered for our webinar
Over 375 industry leaders from 55+ Pharma & Biotech companies registered for our webinar “Leveraging Patient Data and AI for Life Science Product Launches”. The list included Abbott, Amgen, AstraZeneca, BioMarin Pharmaceutical Inc., Bristol Myers Squibb, Biogen, Eli Lilly and Company, Genentech, Gilead Sciences, Jazz Pharmaceuticals, Kyowa Kirin, Inc.- U.S., Reata Pharmaceuticals, Inc., The Janssen Pharmaceutical Companies of Johnson & Johnson, Merck, Merck Group, Moderna, Novartis, PTC Therapeutics, Inc., Regeneron, Takeda, Takeda Oncology, Sanofi, UCB, Pfizer and many others. In this webinar, […]
Clinakos at ML@B Career Fair
Thank you University of California, Berkeley and Machine Learning at Berkeley for inviting Clinakos Inc. to recruit for open positions at the 2023 UC Berkeley-ML@B Career Fair. It was an amazing experience to discuss #AI, #ML and #GenerativeAI with some of the smartest AI/ML brains in the world. Over 100 recent graduate and undergraduate students […]
Thoughts on EDS Patient Story
Stephanie Aston, 33, died at her New Zealand home on September 1 after a public battle with Ehlers-Danlos Syndrome (EDS) — a genetic disorder she was accused of faking. Stephanie had a family history of EDS, a serious disorder associated with connective tissues. Unfortunately, Stephanie was accused by her physician of faking her symptoms. Instead […]
Patient Data: Emerging Opportunities for Rare Diseases, Cell & Gene Therapies and Oncology
Patient data has the potential to transform all aspects of life sciences product development and commercialization. In this session, you will hear from the CEO of a cell and gene therapy company with a late-stage investigational therapeutic for a rare disease. He will present his perspectives on how patient data can be transformative for rare […]
Clinakos Celebrates Rare Disease Day
Over 300 million people worldwide are affected by rare diseases. Rare diseases impact the lives of people of all races, religions, and socio-economic status. Clinakos is proud to support the Rare Disease Patients and Life science partners in developing and commercializing cures via our unique data & solution offerings for >700 Rare, Oncology and Non-Rare […]
Meet us at JPMorgan Chase & Co.’s 41st Annual JP Morgan Healthcare Conference
Meet Clinakos Inc. at JPMorgan Chase & Co.‘s 41st Annual JP Morgan Healthcare Conference in San Francisco. Our team is here till Thursday Jan 12th meeting with clients, partners and anyone else who shares our vision of democratizing patient data for research and patient car.
Meet us at HLTH 2022
Meet Clinakos Inc. at HLTH2022 to learn about how recent regulation changes provide an opportunity for Pharmaceutical Companies to leverage patient data for multiple use cases. If you are attending and want to meet, please email sales@clinakos.com
